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Sepsis Syndrome in Croatian Intensive Care Units: Piloting a National 
Comparative Clinical Database
Aim To assess the incidence of sepsis in selected intensive care units 
(ICUs) in Croatia, isolates from blood cultures, and sepsis outcomes, 
and to compare the results with those from other European coun-
tries.
Methods In the pilot phase of the national comparative clinical da-
tabase project, we included 24 ICUs – general, specialized, neonatal, 
pediatric, and adult – 18 from university hospitals, 3 from county 
hospitals, and 4 from city hospitals. By retrospective chart review, 
trained data collectors abstracted the data on the case mix, manage-
ment strategies, and outcomes in patients consecutively admitted to 
ICUs. Central validation for incomplete, illogical, or inconsistent val-
ues is regularly performed to improve accurateness.
Results Of 5293 patients treated in 24 ICUs from November 1, 2004, 
to October 31, 2005, 456 (8.6%) were treated for sepsis syndrome or 
severe sepsis. The most common isolates from positive blood cultures 
were Esherichia coli (11.6%), Pseudomonas species (9.9%), and methi-
cillin-resistant Staphylococcus aureus (9.3%). With the mean Acute 
Physiology and Chronic Health Evaluation (APACHE) II score of 
10.0 and Sequential Organ Failure Assessment (SOFA) score of 2.4, 
the overall mortality for sepsis syndrome, severe sepsis, and septic 
shock was 29%, 35%, and 34%, respectively. When compared to uni-
versity hospitals and county hospitals, city hospitals with the small-
est gravitating population had significantly lower APACHE II and 
SOFA scores, but significantly higher mortality.
Conclusions Overall mortality of patients with sepsis syndrome in 
Croatian ICUs was high, but outcomes of their treatment were com-
parable with those in other European countries. Better education in 
triage and treatment strategies is needed, including better implemen-
tation of Surviving Sepsis Campaign guidelines.
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The sepsis syndrome, severe sepsis, and septic 
shock represent a major therapeutic and econom-
ic problem. In the intensive care units (ICUs) in 
the European Union (EU) member states, severe 
sepsis and septic shock result in 135 000 deaths 
per year with associated costs of €7.6 billion (1). 
The meeting of the European Society on Inten-
sive Care Medicine in Barcelona in 1992 resulted 
in the Declaration on the need for standardiza-
tion of diagnostics, treatment strategy, and out-
come analysis in these patients (2). A large Sepsis 
Occurrence in Acutely ill Patients (SOAP) study 
provided data on the incidence of sepsis in the 
ICUs in EU member states, patients’ character-
istics, management, and outcomes (3). Data on 
the incidence of sepsis in central European coun-
tries are less available. The Croatian National In-
stitute of Public Health collects the national data 
on the incidence of sepsis, but does not collect 
any additional data, such as those on treatment 
or outcomes. Also, the incidence data are consid-
ered to be incomplete (4).
The croicu.net project was started in Novem-
ber 2004 to fill the gap in documenting the case 
mix, treatments, and outcomes in Croatian ICUs 
(5). The still ongoing pilot phase rests on volun-
tary participation of 24 ICUs. The final aim is to 
establish a national clinical database that would 
inform policy and foster professional develop-
ment through enabling comparative audits of 
ICUs nationwide. We analyzed the data collect-
ed through croicu.net from November 1, 2004, 
to October 31, 2005, to assess the incidence of 
sepsis in the Croatian ICUs participating in the 
project, isolates from blood cultures, and out-
comes, and to compare Croatian data with those 
from other European countries.
Methods
In the fall of 2004, 24 of a total of 120 ICUs in 
Croatia joined the pilot phase of the study with-
in the croicu.net project. The ICUs are of differ-
ent profiles, from neonatal and pediatric to adult, 
and from general to specialized. Eighteen ICUs 
are located in university hospitals, 3 in large or 
county general hospitals (50 000-100 000 gravi-
tating population), and 4 in city general hospi-
tals (5000-10 000 gravitating population). The 
participating ICUs roughly cover almost 1.2 mil-
lion people, or a quarter of the total population 
of Croatia.
One representative from each ICU attended 
the initial meeting in the fall of 2004 where the 
project was explained in detail and representa-
tives trained for data collection according to pre-
cise rules and definitions. All data collectors were 
resident or consultant physicians.
From November 1, 2004, all participating 
ICUs started to collect a set of data for each pa-
tient leaving the ICU. Abstraction is performed 
by filling out a form based on a retrospective 
chart review. The form contains each patient’s 
identifier, type of admission, demographic data, 
and data on the case mix, management, outcome, 
and length of hospital stay. Each participating 
ICU received a software for automatic score cal-
culation, along with the Surviving Sepsis Cam-
paign guidelines. The software for calculation of 
Acute Physiology and Chronic Health Evalua-
tion (APACHE) II and Sequential Organ Fail-
ure Assessment (SOFA) scores for adults, and 
Pediatric Index of Mortality (PIM) 2 and Neo-
natal Therapeutic Intervention Scoring System 
(NTISS) scores for children and neonates, al-
lows for data entry directly into the form (6-8). 
It has been estimated to take 8-20 minutes to ab-
stract the data for one patient, depending on the 
abstractor’s experience and the amount of inter-
ventions that the patient received.
Data are collected on consecutive admissions 
and uploaded on croicu.net by each participating 
ICU. Every three months, data are checked cen-
trally for completeness, illogicality, and inconsis-
tencies. Cumulative reports, also available online, 
are sent to each participating ICU. In the pilot 
phase of the project, all participating ICUs have 
access only to their own data and report analyses. 
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We report on the sepsis syndrome data collected 
during the first year of the ongoing project, from 
November 1, 2004, to October 31, 2005.
Definitions
Sepsis syndrome was defined as a confirmed or 
presumed (all blood cultures negative) infection 
with fever of 38°C or hypothermia of 35.5°C, 
tachypnea of 20 or more inspirations/min, tachy-
cardia of 90 beats/min or more, leukocytosis 
>10 000 white blood cells or bands over 10, and 
positive blood culture finding. Sepsis was diag-
nosed when at least two of these parameters were 
found in a patient. Severe sepsis was defined as 
sepsis syndrome with failure of two organs. Sep-
tic shock was defined as circulatory instability in 
sepsis, ie, hypotension of <100 mm Hg despite 
volume replacement (9).
Statistical analysis
For statistical analyses, we used χ2 test for discrete 
variables and Kruskal-Wallis test for continuous 
variables. P<0.05 was considered to be statistically 
significant. We used MedCalc (MedCalc Software, 
Mariakerke, Belgium) software for all analyses.
Results
Over the one-year period, a total of 5293 patients 
were hospitalized in the 24 ICUs. With 8.6% of 
all admissions (456 patients), sepsis and severe 
sepsis were the third most common reason, close-
ly following myocardial infarction and pulmo-
nary edema, for admission in the included ICUs 
(Table 1). With respect to the case mix, there 
was a significant difference in APACHE II score 
and SOFA score between the university, county, 
and city hospital-based ICUs. APACHE II score 
and SOFA score were significantly higher in uni-
versity and county hospital ICUs than in city 
hospital ICUs (P<0.001) (Table 2). These dif-
ferences were even more pronounced after coro-
nary care units were excluded from the analyses. 
Overall mortality and mortality in patients with 
sepsis was significantly higher in the city hospital 
ICUs than university and county hospital ICUs 
(Table 3). These differences were even more pro-
nounced after coronary care units were exclud-
ed from the analyses. The most common isolates 
from positive blood cultures in patients with 
sepsis syndrome were Escherichia coli (11.6%) 
and Pseudomonas species (9.9%) (Table 4). In 
all three groups of ICUs, >70% of patients with 
sepsis syndrome had sepsis at admission, where-
as the rest of the patients developed sepsis during 
hospital stay (Table 5). The three groups of ICUs 
did not significantly differ according to the per-
centages of patients who were admitted with sep-
sis or developed sepsis during hospital stay.
Discussion
A large European SOAP study provided exten-
sive comparative data on sepsis syndrome in Eu-
Table 1. The most common 10 diagnoses of patients admitted to 
the 24 intensive care units (ICUs) in Croatia from November 1, 
2004, to October 31, 2005
Diagnosis No. (%) of patients
Myocardial infarction  592 (11.2)
Pulmonary edema  542 (10.2)
Sepsis and severe sepsis  456 (8.6)
Coronary artery bypass graft  396 (7.5)
Renal failure  373 (7.0)
Abdominal neoplasm surgery  357 (6.7)
Other abdominal surgery  344 (6.5)
Shock  305 (5.8)
Tachyarrhythmia  276 (5.2)
Respiratory insufficiency  256 (4.8)
Total 3897 (73.5)
Table 2. Characteristics, mortality, and length of stay of patients 
admitted to university, county, and city hospital-based intensive 
care units in Croatia from November 1, 2004, to October 31, 
2005*
Mean±SD for type of hospital  †
Parameter university county city Total
No. of patients 3794 602 897 5293
No. (%) of men‡ 2314 (60.1) 365 (60.6) 457 (50.9) 2509 (59.4)
Age (y)†   60 ± 18   64 ± 16  63 ± 17   60 ± 17
APACHE II score† 11.1 ± 6.4 11.1 ± 6.6 5.6 ± 6.5 10.0 ± 7.6
SOFA score†  3.1 ± 3.0  1.3 ± 1.9 0.5 ± 1.5  2.4 ± 2.9
Length of stay (days) †  4.9 ± 5.4  4.1 ± 5.5 4.1 ± 6.0  4.8 ± 6.4
No. (%) of deaths‡  448 (11.8)  69 (11.5) 110 (12.3)  627 (11.9)
*Abbreviations: SD – standard deviation; APACHE – Acute Physiology and Chronic 
Health Evaluation score; SOFA – sequential organ failure assessment score; ICU 
– intensive care unit.
†Kruskal-Wallis test, P<0.001 for all in adult ICUs.
‡χ2 test, P<0.001 for proportion of men and P = 0.451 for proportion of deaths in adult 
ICUs.
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ropean ICUs (3) and showed that sepsis was the 
reason for ICU admission in 37.4% of patients. 
The most common infection sites were the lungs 
and the abdomen, and the most common caus-
ative agents were Staphylococcus aureus, includ-
ing methicillin-resistant form, Pseudomonas, and 
Escherichia coli. The overall mortality ranged be-
tween 18.5% and 24.1% and it depended on age, 
circulatory insufficiency, malignant disease, and 
positive fluid balance.
The croicu.net project provided for the first 
time data from Croatian ICUs that are suitable 
for national and international comparisons and 
should stimulate improvements in the manage-
ment and outcomes of sepsis syndrome and pol-
icy making. Our data showed the overall inci-
dence of sepsis syndrome in the included ICUs 
of 8.6% and overall mortality of 29.1%, similar 
to those recently published for the ICUs in the 
Republic of Slovakia (10). Total mortality rate 
in our patients with severe sepsis was lower than 
that reported in the literature, which can be ex-
plained by lower APACHE II and SOFA score 
in our patients. Similarly, the Episepsis Study 
found the incidence of severe sepsis in French 
ICUs of 8.4% and mortality of 56% (11). In Po-
land, a project similar to croicu.net that stemmed 
from the same project from the UK (12), start-
Table 3. Patients with sepsis, severe sepsis, and septic shock and mortality rates in 24 intensive care units according to the type of 
hospital*
Mean±SD for type of hospital  
Diagnosis university county city Total P
No. of patients 3794 602 897 5293
No. (%) of deaths  448 (11.8)  69 (11.5) 110 (12.3)  627 (11.9) <0.001‡
Sepsis:
 No. (%) of patients  247 (6.5)  22 (3.6)   9 (1.1)  278 (5.2) <0.001‡
 APACHE II score 18.2 ± 5.2 16.3 ± 7.3 16.1 ± 5.4 17.9 ± 6.2 <0.001†
 SOFA score  6.3 ± 1.5  5.2 ± 2.0  5.3 ± 2.2  6.0 ± 1.9 <0.001†
 No. (%) of deaths   71 (28.7)   7 (31.8)   5 (55.5)   83 (29.1)  0.001‡
Severe sepsis:
 No. (%) of patients  157 (4.1)  15 (2.5)   8 (0.8)  180 (3.4) <0.001‡
 APACHE II score 20.1 ± 4.9 18.8 ± 6.1 18.9 ± 7.4 19.5 ± 6.2 <0.001†
 SOFA score  6.9 ± 3.4  6.1 ± 2.5  6.1 ± 3.0  6.8 ± 3.4  0.002†
 No. (%) of deaths   52 (33.3)   6 (40.0)   5 (62.5)   63 (35.0) <0.001‡
Septic shock:
 No. (%) of patients  111 (2.9)  14 (2.3)   4 (0.5)  129 (2.4) <0.001‡
 APACHE II score 21.3 ± 4.9 19.9 ± 5.4 19.7 ± 5.0 21.0 ± 6.1  0.008†
 SOFA score  7.2 ± 3.1  7.1 ± 2.8  8.0 ± 4.8  7.3 ± 3.2  0.127†
 No. (%) of deaths   36 (32.4)   5 (35.7)   3 (75.0)   44 (34.1)  0.045‡
*Abbreviations: ICU – intensive care unit; APACHE – Acute Physiology and Chronic Health Evaluation score; SOFA – sequential organ failure assessment score.
†Kruskal-Wallis test, adult ICUs only.
‡χ2 test, adult ICUs only.
Table 4. Isolates from blood cultures in patients with sepsis 
syndrome
Infective agent No. (%) of patients
Escherichia coli  41 (11.6)
Pseudomonas spp.  35 (9.9)
Methicillin-resistant Staphylococcus aureus  33 (9.3)
Klebsiella pneumoniae  16 (4.5)
Staphylococcus aureus  16 (4.5)
Proteus spp.  15 (4.2)
Candida albicans  11 (3.1)
Staphylococcus epidermidis  11 (3.1)
Streptococcus pneumoniae  11 (3.1)
Enterococcus  10 (2.8)
Streptococcus B-H   9 (2.5)
Gram negative bacteria   9 (2.5)
Methicillin-resistant Staphylococcus epidermidis   8 (2.3)
Enterobacter spp.   8 (2.3)
Acinetobacter   7 (2.0)
Hemofillus influenzae   4 (1.1)
All other  25 (7.1)
Negative blood cultures  84 (23.8)
Total 328 (100.0)
Table 5. Incidence of sepsis, severe sepsis, and septic shock on 
intensive care unit (ICU) admission and sepsis developed in the 
ICU according to the type of hospital
No. (%) of patients with*
Type of hospital sepsis on admission sepsis developed in ICU
University 382 (74.3) 132 (25.7)
County  37 (72.6)  14 (27.3)
City  15 (71.4)   6 (28.6)
*χ2 test, P = 0.926.
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ed in 2003 and provided the first international-
ly comparable data for that country. Moreover, 
the project provided the first data ever on the in-
cidence of severe sepsis in Poland. The study re-
ported overall mortality of 55% (13). The mor-
tality rate of the patients with septic shock and 
severe sepsis in our pilot study was the same, but 
the groups were too small to allow for any con-
clusion.
It seems that the incidence of severe sepsis 
and septic shock in ICUs in developed countries 
has increased in the previous years. In France, a 
prospective 3-year study found the incidence of 
severe sepsis of 42% (14). The same study showed 
that many patients developed sepsis during ICU 
stay rather than having it at admission and that 
mortality rates increased. In our pilot study, sep-
sis syndrome during ICU stay developed in 27% 
of all patients with confirmed sepsis.
Recording causative agents and their resis-
tance to antibiotics is immensely important for 
future management and outcomes of sepsis syn-
drome, especially the continuous antibiogram 
monitoring (15). A Polish study recently found 
that the incidence of gram negative and gram 
positive causative agents in their ICUs was al-
most identical (13). The incidence of mycotic in-
fections varies from about 20% in Polish ICUs 
(13) to about 4% in Croatia (this study). Euro-
pean epidemiological data showed that Candida 
albicans was the most common causative agent, 
most often in hematological patients, with a high 
mortality rate of 37.9% (16).
The most common isolates from positive 
blood cultures in the Croatian ICUs were Esch-
erichia coli, Pseudomonas species, and methicillin-
resistant Staphylococcus aureus. These findings are 
similar to those of the SOAP study. Other stud-
ies also observed a high incidence of gram nega-
tive causative agents, for example Acinetobacter 
Baumanii in patients with ventilator-associated 
bacterial pneumonia associated with previous an-
tibiotic treatment, use of corticosteroids, and the 
need for renal replacement therapy (17).
Croatian ICUs systematically differed in 
the case mix and mortality rates. While patients 
treated in city hospital ICUs had significantly 
lower APACHE II and SOFA scores than pa-
tients treated in university and county hospitals, 
city hospital ICUs also had significantly higher 
mortality rates. Such findings point to the need 
for better triage of patients hospitalized in ICUs 
of smaller cities, which would also reduce cost, 
and for better education on treatment strategy, 
including the implementation of the Surviving 
Sepsis Campaign guidelines. However, our pi-
lot analysis did not adequately adjust for the case 
mix in spite of APACHE II and SOFA scoring 
and thus does not permit for drawing firm con-
clusions.
The most common management of patients 
with severe sepsis in the Croatian ICUs was re-
placement of respiratory function (data not 
shown). Thus far, it seems that different forms of 
non-invasive mechanical ventilation, now avail-
able and recommended over invasive forms of 
mechanical ventilation (18), are used only spo-
radically in Croatia. On the contrary, it seems 
that continuous veno-venous hemofiltration was 
more common than intermittent hemodyalisis 
(19), although the most common form of extra-
corporeal circulation used for renal function re-
placement seems to differ between the ICUs 
(data not shown).
Our analysis suggests that the epidemiologi-
cal data on the incidence of sepsis, length of hos-
pital stay, and mortality should be considered at 
the individual hospital level rather than national 
level. The ongoing construction of clinical data-
base should include all ICUs in Croatia and thus 
provide the platform for national comparative 
audits in the future. However, at this pilot stage, 
the variability of included ICUs does not permit 
robust comparisons and conclusions. Other limi-
tations of our project currently include the lack 
of local control of data collection and data vali-
dation. Also, since the coverage of the Croatian 
population by the included ICUs is still uneven, 
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we are not yet able to calculate population-based 
parameters.
The Surviving Sepsis Campaign aims to re-
duce the severe sepsis mortality by 25% in 5 
years, by disseminating and implementing gener-
ally accepted treatment guidelines (20,21). Croa-
tia’s participation in the campaign has the poten-
tial to improve the management and outcomes 
of sepsis syndrome, severe sepsis, and septic shock 
in Croatian ICUs. The provision of adequate 
comparative data has been a great challenge for 
us (22). We believe that croicu.net will, in the 
absence of a sepsis register, provide a robust ba-
sis for the national and international comparison 
of parameters and improve the management and 
outcomes of patients with sepsis syndrome in the 
Croatian ICUs.
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